Cluster analysis to estimate the risk of preeclampsia in the high-risk Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study

被引:20
|
作者
Villa, Pia M. [1 ,2 ]
Marttinen, Pekka [3 ]
Gillberg, Jussi [3 ]
Lokki, A. Inkeri [2 ,4 ,5 ,6 ]
Majander, Kerttu [7 ]
Orden, Maija-Riitta [8 ]
Taipale, Pekka [9 ]
Pesonen, Anukatriina [10 ]
Raikkonen, Katri [10 ]
Hamalainen, Esa [2 ,11 ]
Kajantie, Eero [12 ,13 ,14 ,15 ,16 ,17 ]
Laivuori, Hannele [1 ,2 ,18 ]
机构
[1] Univ Helsinki, Obstet & Gynaecol, Helsinki, Finland
[2] Helsinki Univ Hosp, Helsinki, Finland
[3] Aalto Univ, Helsinki Inst Informat Technol, Dept Comp Sci, Espoo, Finland
[4] Univ Helsinki, Res Programs Unit, Immunobiol, Helsinki, Finland
[5] Univ Helsinki, Med & Clin Genet, Helsinki, Finland
[6] Univ Helsinki, Bacteriol & Immunol, Helsinki, Finland
[7] Univ Tubingen, Inst Archaeol Sci, Tubingen, Germany
[8] Kuopio Univ Hosp, Obstet & Gynecol, Kuopio, Finland
[9] Suomen Terveystalo Oy, Kuopio, Finland
[10] Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland
[11] Univ Helsinki, HUSLAB, Helsinki, Finland
[12] Natl Inst Hlth & Welf, Helsinki, Finland
[13] Natl Inst Hlth & Welf, Oulu, Finland
[14] Oulu Univ Hosp, MRC Oulu, PEDEGO Res Unit, Oulu, Finland
[15] Univ Oulu, Oulu, Finland
[16] Helsinki Univ Hosp, Childrens Hosp, Helsinki, Finland
[17] Univ Helsinki, Helsinki, Finland
[18] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland
来源
PLOS ONE | 2017年 / 12卷 / 03期
基金
芬兰科学院;
关键词
LOW-DOSE ASPIRIN; PREGNANCY COMPLICATIONS; WOMEN; VALIDITY; REGISTRY;
D O I
10.1371/journal.pone.0174399
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives Preeclampsia is divided into early-onset (delivery before 34 weeks of gestation) and late-onset (delivery at or after 34 weeks) subtypes, which may rise from different etiopathogenic backgrounds. Early-onset disease is associated with placental dysfunction. Late-onset disease develops predominantly due to metabolic disturbances, obesity, diabetes, lipid dysfunction, and inflammation, which affect endothelial function. Our aim was to use cluster analysis to investigate clinical factors predicting the onset and severity of preeclampsia in a cohort of women with known clinical risk factors. Methods We recruited 903 pregnant women with risk factors for preeclampsia at gestational weeks 12(+0)-13(+6). Each individual outcome diagnosis was independently verified from medical records. We applied a Bayesian clustering algorithm to classify the study participants to clusters based on their particular risk factor combination. For each cluster, we computed the risk ratio of each disease outcome, relative to the risk in the general population. Results The risk of preeclampsia increased exponentially with respect to the number of risk factors. Our analysis revealed 25 number of clusters. Preeclampsia in a previous pregnancy (n = 138) increased the risk of preeclampsia 8.1 fold (95% confidence interval (CI) 5.711.2) compared to a general population of pregnant women. Having a small for gestational age infant (n = 57) in a previous pregnancy increased the risk of early-onset preeclampsia 17.5 fold (95%CI 2.160.5). Cluster of those two risk factors together (n = 21) increased the risk of severe preeclampsia to 23.8-fold (95%CI 5.160.6), intermediate onset (delivery between 34(+0)-36(+6) weeks of gestation) to 25.1-fold (95%CI 3.179.9) and preterm preeclampsia (delivery before 37(+0) weeks of gestation) to 16.4-fold (95%CI 2.052.4). Body mass index over 30 kg/m(2) (n = 228) as a sole risk factor increased the risk of preeclampsia to 2.1-fold (95%CI 1.13.6). Together with preeclampsia in an earlier pregnancy the risk increased to 11.4 (95%CI 4.520.9). Chronic hypertension (n = 60) increased the risk of preeclampsia 5.3-fold (95%CI 2.49.8), of severe preeclampsia 22.2-fold (95%CI 9.941.0), and risk of early-onset preeclampsia 16.7-fold (95%CI 2.057.6). If a woman had chronic hypertension combined with obesity, gestational diabetes and earlier preeclampsia, the risk of term preeclampsia increased 4.8-fold (95%CI 0.121.7). Women with type 1 diabetes mellitus had a high risk of all subgroups of preeclampsia. Conclusion The risk of preeclampsia increases exponentially with respect to the number of risk factors. Early-onset preeclampsia and severe preeclampsia have different risk profile from term preeclampsia.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Cohort Profile: Prediction and prevention of preeclampsia and intrauterine growth restriction (PREDO) study
    Girchenko, Polina
    Lahti, Marius
    Tuovinen, Soile
    Savolainen, Katri
    Lahti, Jari
    Binder, Elisabeth B.
    Reynolds, Rebecca M.
    Entringer, Sonja
    Buss, Claudia
    Wadhwa, Pathik D.
    Hamalainen, Esa
    Kajantie, Eero
    Pesonen, Anu-Katriina
    Villa, Pia M.
    Laivuorillt, Hannele
    Raikkonen, Katri
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2017, 46 (05) : 1380 - +
  • [2] Angiogenic factors for prediction of preeclampsia and intrauterine growth restriction onset in high-risk women: AngioPred study
    Raia-Barjat, Tiphaine
    Prieux, Carole
    Gris, Jean-Christophe
    Chapelle, Celine
    Laporte, Silvy
    Chauleur, Celine
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2019, 32 (02): : 248 - 257
  • [3] Aspirin for the Prevention of Preeclampsia and Intrauterine Growth Restriction
    Roberge, Stephanie
    Odibo, Anthony O.
    Bujold, Emmanuel
    [J]. CLINICS IN LABORATORY MEDICINE, 2016, 36 (02) : 319 - +
  • [4] Early Prediction of Preeclampsia in High-Risk Women
    Shaker, Olfat Gamil
    Shehata, Hany
    [J]. JOURNAL OF WOMENS HEALTH, 2011, 20 (04) : 539 - 544
  • [5] PlGF in a clinical setting of pregnancies at risk of preeclampsia and/or intrauterine growth restriction
    Cetin, Irene
    Mazzocco, Martina I.
    Giardini, Valentina
    Cardellicchio, Manuela
    Calabrese, Stefania
    Algeri, Paola
    Martinelli, Anna
    Todyrenchuk, Lyudmyla
    Vergani, Patrizia
    [J]. Journal of Maternal-Fetal & Neonatal Medicine, 2017, 30 (02): : 144 - 149
  • [6] Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction
    Tjoa, ML
    Oudejans, CBM
    van Vugt, JMG
    Blankenstein, MA
    van Wijk, IJ
    [J]. HYPERTENSION IN PREGNANCY, 2004, 23 (02) : 171 - 189
  • [7] Aspirin and Pravastatin for Preeclampsia Prevention in High-Risk Pregnancy
    Eid, Joe
    Rood, Kara M.
    Costantine, Maged M.
    [J]. OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2023, 50 (01) : 79 - 88
  • [8] Pravastatin for the Prevention of Preeclampsia in High-Risk Pregnant Women
    Costantine, Maged M.
    Cleary, Kirsten
    [J]. OBSTETRICS AND GYNECOLOGY, 2013, 121 (02): : 349 - 353
  • [9] Angiogenic factors for the prediction of preeclampsia in high-risk women
    Simas, Tiffany A. Moore
    Crawford, Sybil L.
    Solitro, Matthew J.
    Frost, Sara C.
    Meyer, Bruce A.
    Maynard, Sharon E.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (03) : 244.e1 - 244.e8
  • [10] Comparison of preeclampsia and fetal growth restriction screenings at first trimester in a high-risk population
    Romero Infante, Ximena Carolina
    Uriel, Montserrat
    Porras Ramirez, Alexandra
    Rincon Franco, Sara
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (02) : 765 - 773